Results 1 to 10 of about 5,265,871 (311)

Orf – an orphan disease? [PDF]

open access: yesJRSM Open, 2015
Human orf should be considered based on a typical presentation with erythematous papule/nodule to avoid unnecessary over-treatment.
Rahel Meier   +4 more
doaj   +6 more sources

T2-Low Asthma: A Discussed but Still Orphan Disease [PDF]

open access: yesBiomedicines, 2023
Asthma affects 10% of the worldwide population; about 5% of cases are severe with the need for target therapies such as biologics. All the biologics approved for asthma hit the T2 pathway of inflammation.
Francesca Peri   +5 more
doaj   +2 more sources

Drug repositioning for orphan diseases. [PDF]

open access: yesBriefings in Bioinformatics, 2011
The need and opportunity to discover therapeutics for rare or orphan diseases are enormous. Due to limited prevalence and/or commercial potential, of the approximately 6000 orphan diseases (defined by the FDA Orphan Drug Act as
Anil G. Jegga, Minlu Zhang, Lun Yang
exaly   +4 more sources

Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle, 2019
Anker MS   +10 more
europepmc   +2 more sources

Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder

open access: yesMobile DNA, 2021
Background Retrotransposons have been implicated as causes of Mendelian disease, but their role in autism spectrum disorder (ASD) has not been systematically defined, because they are only called with adequate sensitivity from whole genome sequencing ...
Rebeca Borges-Monroy   +9 more
doaj   +1 more source

The Orphan Disease Networks [PDF]

open access: yesThe American Journal of Human Genetics, 2011
The low prevalence rate of orphan diseases (OD) requires special combined efforts to improve diagnosis, prevention, and discovery of novel therapeutic strategies. To identify and investigate relationships based on shared genes or shared functional features, we have conducted a bioinformatic-based global analysis of all orphan diseases with known ...
Zhang, Minlu   +4 more
openaire   +2 more sources

Sharing is caring: a call for a new era of rare disease research and development

open access: yesOrphanet Journal of Rare Diseases, 2022
Scientific advances in the understanding of the genetics and mechanisms of many rare diseases with previously unknown etiologies are inspiring optimism in the patient, clinical, and research communities and there is hope that disease-specific treatments ...
Nathan Denton   +6 more
doaj   +1 more source

A data-driven architecture using natural language processing to improve phenotyping efficiency and accelerate genetic diagnoses of rare disorders

open access: yesHGG Advances, 2021
Summary: Effective genetic diagnosis requires the correlation of genetic variant data with detailed phenotypic information. However, manual encoding of clinical data into machine-readable forms is laborious and subject to observer bias.
Jignesh R. Parikh   +21 more
doaj   +1 more source

Data silos are undermining drug development and failing rare disease patients

open access: yesOrphanet Journal of Rare Diseases, 2021
Data silos are proliferating while research and development activity explode following genetic and immunological advances for many clinically described disorders with previously unknown etiologies.
Nathan Denton   +7 more
doaj   +1 more source

Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States

open access: yesOrphanet Journal of Rare Diseases, 2023
Background X-linked myotubular myopathy (XLMTM) is a rare, life-threatening congenital myopathy with multisystem involvement, often requiring invasive ventilator support, gastrostomy tube feeding, and wheelchair use.
Robert J. Graham   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy